Growing community of inventors

Boston, MA, United States of America

David Schenkein

Average Co-Inventor Count = 6.18

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 19

David SchenkeinKatharine Yen (4 patents)David SchenkeinNelamangala Nagaraja (4 patents)David SchenkeinBrandon Nicolay (4 patents)David SchenkeinJoshua Murtie (4 patents)David SchenkeinYanfeng Zhang (3 patents)David SchenkeinChong-Hui Gu (3 patents)David SchenkeinSamuel V Agresta (3 patents)David SchenkeinHua Yang (3 patents)David SchenkeinLiting Guo (3 patents)David SchenkeinJianming Wang (3 patents)David SchenkeinZhen Tang (3 patents)David SchenkeinYan Zhou (3 patents)David SchenkeinDavid Schenkein (7 patents)Katharine YenKatharine Yen (5 patents)Nelamangala NagarajaNelamangala Nagaraja (4 patents)Brandon NicolayBrandon Nicolay (4 patents)Joshua MurtieJoshua Murtie (4 patents)Yanfeng ZhangYanfeng Zhang (59 patents)Chong-Hui GuChong-Hui Gu (19 patents)Samuel V AgrestaSamuel V Agresta (14 patents)Hua YangHua Yang (5 patents)Liting GuoLiting Guo (4 patents)Jianming WangJianming Wang (4 patents)Zhen TangZhen Tang (3 patents)Yan ZhouYan Zhou (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Agios Pharmaceuticals, Inc. (5 from 96 patents)

2. Servier Pharmaceuticals LLC (2 from 21 patents)


7 patents:

1. 12064436 - Methods of treating brain tumors using combination therapy

2. 12042497 - Methods of treating brain tumors using combination therapy

3. 11458127 - Methods of treating brain tumors using combination therapy

4. 10780093 - Methods of treating brain tumors using combination therapy

5. 10730854 - Therapeutically active compounds and their methods of use

6. 10093654 - Therapeutically active compounds and their methods of use

7. 9738625 - Therapeutically active compounds and their methods of use

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/24/2025
Loading…